Download PDF

Subjects

- Cardiovascular diseases

- Inflammasome

- Translational research

The Original Article was published on 17 March 2021

Correction to: Nature https://doi.org/10.1038/s41586-021-03341-5 Published online 17 March 2021

In the version of this article initially published, due to mistakes during file revision and figure assembly, there was a duplication error in Extended Data Fig. 10l, where the top-right 20% Control IL-1β image was a repeat of the lower-left 20% Jak2VF IgG image. In the initial submission, where current Extended Data Fig. 10l was originally presented as Fig. 4d, the correct 20% Control IL-1β H&E stain was included. Due to the age of the article, Extended Data Fig. 10l cannot be updated directly; the correct image, in submitted Fig. 4d, can be accessed in the Supplementary Information accompanying this amendment.

Supplementary information is available in the online version of this amendment.

Author information

Author notes- These authors jointly supervised this work: Nan Wang, Alan R. Tall

Authors and Affiliations

- Division of Molecular Medicine, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA

Trevor P. Fidler, Mustafa Yalcinkaya, Brian Hardaway, Sandra Abramowicz, Tong Xiao, Wenli Liu, David G. Thomas, Marit Westerterp, Nan Wang & Alan R. Tall

- Cardiometabolic Precision Medicine Program, Cardiology Division, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA

Chenyi Xue & Muredach P. Reilly

- Irving Institute for Clinical and Translational Research, Columbia University Irving Medical Center, New York, NY, USA

Chenyi Xue & Muredach P. Reilly

- Medical Clinic I., Department of Cardiology, LMU Klinikum, Ludwig Maximilian University, Munich, Germany

Mohammad Ali Hajebrahimi, Joachim Pircher, Christian Schulz & Steffen Massberg

- German Center for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, Munich, Germany

Mohammad Ali Hajebrahimi, Joachim Pircher, Carlos Silvestre-Roig, Christian Schulz, Steffen Massberg & Oliver Soehnlein

- Institute for Cardiovascular Prevention (IPEK), LMU Munich, Munich, Germany

Carlos Silvestre-Roig & Oliver Soehnlein

- Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Andriana G. Kotini & Eirini P. Papapetrou

- Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Andriana G. Kotini & Eirini P. Papapetrou

- Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Andriana G. Kotini & Eirini P. Papapetrou

- Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Andriana G. Kotini & Eirini P. Papapetrou

- Department of Medicine, Columbia Center for Human Development, Columbia University Irving Medical Center, New York, NY, USA

Larry L. Luchsinger & Hans-Willem Snoeck

- Columbia University, New York, NY, USA

Ying Wei

- Department of Pediatrics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands

Marit Westerterp

- Department of Physiology and Pharmacology (FyFa), Karolinska Institute, Stockholm, Sweden

Oliver Soehnlein

- Department of Medical Oncology, Dana-Faber Cancer Institute, Boston, MA, USA

Benjamin Ebert

- Howard Hughes Medical Institute, Dana-Faber Cancer Institute, Boston, MA, USA

Benjamin Ebert

- Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA

Ross L. Levine

- Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, USA

Ross L. Levine

- Department of Medicine, Cardiovascular Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA

Peter Libby

Authors- Trevor P. FidlerView author publications